|
NUDT17 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.803400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.245180E-01 |
| Normal-vs-Stage2 |
5.761400E-01 |
| Normal-vs-Stage3 |
1.960060E-02 |
| Normal-vs-Stage4 |
3.243500E-04 |
| Stage1-vs-Stage2 |
7.250000E-01 |
| Stage1-vs-Stage3 |
1.877230E-01 |
| Stage1-vs-Stage4 |
6.160800E-03 |
| Stage2-vs-Stage3 |
2.595400E-01 |
| Stage2-vs-Stage4 |
2.132100E-02 |
| Stage3-vs-Stage4 |
1.302800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.480500E-03 |
| Normal-vs-AfricanAmerican |
7.868000E-01 |
| Normal-vs-Asian |
1.187410E-01 |
| Caucasian-vs-AfricanAmerican |
9.406000E-02 |
| Caucasian-vs-Asian |
7.034400E-01 |
| AfricanAmerican-vs-Asian |
3.613400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.702700E-03 |
| Normal-vs-Female |
8.195800E-02 |
| Male-vs-Female |
3.642600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.366800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.897800E-02 |
| Normal-vs-Age(61-80Yrs) |
2.401500E-03 |
| Normal-vs-Age(81-100Yrs) |
6.040600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.758600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.924600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.887400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.868020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.776200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.108400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.419400E-01 |
| Normal-vs-Grade 2 |
3.193600E-01 |
| Normal-vs-Grade 3 |
3.620600E-03 |
| Normal-vs-Grade 4 |
1.683340E-03 |
| Grade 1-vs-Grade 2 |
5.838800E-01 |
| Grade 1-vs-Grade 3 |
8.016400E-01 |
| Grade 1-vs-Grade 4 |
5.564800E-01 |
| Grade 2-vs-Grade 3 |
3.306100E-02 |
| Grade 2-vs-Grade 4 |
1.453850E-02 |
| Grade 3-vs-Grade 4 |
5.894600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.769800E-01 |
| Normal-vs-ccB subtype |
3.95549999999689E-05 |
| ccA subtype-vs-ccB subtype |
5.40030000051317E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.236200E-03 |
| Normal-vs-N1 |
2.055600E-02 |
| N0-vs-N1 |
1.068970E-01 |
|
|
